VC firm
TCG Crossover
Also known as TCG Crossover Fund I, L.P., TCG Crossover Fund II, L.P., TCG Crossover Fund III, L.P., TCGX
- Investor type
- VC
- Investing status
- Activeas of 2026-09-17Source (opens in a new tab)
- Headquarters
- PALO ALTO, CA, United States
- Latest fund size
- $800MSEC amount sold, as of 2021-01-14Source (opens in a new tab)
- Funds
- 5
Claim, correct or request removal
Record updated 29 September 2026
About
TCG Crossover (“TCGX”) is a science-driven investment firm dedicated to advancing disruptive medicines
Investment approach
- Thesis
- TCG Crossover “TCGX” is an investment firm focused on innovative biotech companies. We invest in visionary entrepreneurs leveraging recent scientific breakthroughs to develop transformative medicines.Source (opens in a new tab)
- Investing status notes
- We support private and public companies building the future of medicine
Funds
- TCG Crossover Fund III, L.P.
- Vintage 2025Main fund
- TCG Crossover Fund II, L.P.
- Vintage 2023Main fund
- TCG Crossover Fund I, L.P.
- $800MVintage 2021, Main fund, SEC amount sold
- TCGX Fund III
- $1.3BMain fund, Announced close
- TCGX Fund II
- $1BMain fund, Announced close
SEC registration
- SEC CIK
- 1839940, 1969281, 2062644
Locations
- Office
- New York, NY, United States
- Office
- Palo Alto, CA, United States
Loading relationship preview